Results 31 to 40 of about 84,780,597 (237)

Estudio de la expresión de receptores de andrógenos, estrógenos y progesterona mediante inmunohistoquímica en pacientes con alopecia frontal fibrosante

open access: yesRevista Médica Clínica Las Condes, 2023
Resumen: Introducción: La alopecia frontal fibrosante (AFF) es una alopecia linfocítica primaria cicatricial, cuya patogenia se desconoce. Se han desarrollado distintos regímenes de tratamientos farmacológicos, siendo el finasteride por sí sólo o en ...
Néstor Carreño-Orellana   +3 more
doaj   +1 more source

The 5-year Cumulative incidence of cardiovascular diseases in those receiving and not receiving 5-alpha reductase inhibitors.

open access: yes, 2015
The 5-year Cumulative incidence of cardiovascular diseases in those receiving and not receiving 5-alpha reductase inhibitors.
Tien-Huang Lin (631773)   +8 more
core   +1 more source

Beneficial Effects of Human Umbilical Cord Blood Mononuclear Cells on Persistent Erectile Dysfunction After Treatment of 5-Alpha Reductase Inhibitor in Rats

open access: yes, 2021
Background: Effects of human umbilical cord blood (HUCB) as a valuable source for stem cell-based therapies have not been studied in persistent post-5-alpha reductase inhibitors (5ARI) erectile dysfunction (PPED)
Ozen, Fatma Zeynep   +7 more
core   +1 more source

Inhibition of sterol biosynthesis in animal cells by 14 alpha-hydroxymethyl sterols.

open access: yesJournal of Lipid Research, 1980
The chemical syntheses of a number of 14 alpha-hydroxymethyl sterols and 14 alpha -hydroxymethyl-15 alpha-hydroxysterols and their derivatives have been pursued to permit evaluation of their activity in the inhibition of sterol biosynthesis in animal ...
G J Schroepfer, Jr   +3 more
doaj   +1 more source

Baseline characteristics for men exposed to 5 alpha reductase inhibitors (5-ARI) and selected non exposed men.

open access: yes, 2015
SD, Standard deviation. ANGII, Angiotensin II Inhibitors. CCI, Charlson weighted comorbidity index. TURP, Transurethral resection of prostateBaseline characteristics for men exposed to 5 alpha reductase inhibitors (5-ARI) and selected non exposed men.
David Robinson (73947)   +3 more
core   +1 more source

Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors. [PDF]

open access: yes, 2020
Currently, the main available treatments for benign prostate hyperplasia (BPH) are alpha-1 adrenergic receptor antagonists (ARAs), 5-alpha reductase inhibitors (5-αRI), anticholinergics, and Phosphodiesterase-5 inhibitors.
Mohammad R. Hamad   +5 more
core   +1 more source

Kaplan-Meier failure curves of developing cardiovascular diseases in the patients receiving and not receiving 5-alpha reductase inhibitors.

open access: yes, 2015
Kaplan-Meier failure curves of developing cardiovascular diseases in the patients receiving and not receiving 5-alpha reductase inhibitors.
Tien-Huang Lin (631773)   +8 more
core   +1 more source

Ribonucleotide reductase in dividing cells: Purification and inhibition studies with 4-hydroxynonenal [PDF]

open access: yes, 1992
This thesis was submitted for the degree of Doctor of Philosophy and was awarded by Brunel University.1). The effect of temperature, P450 inhibitors (pyrazole and imidazole), sulphydryl reagents (iodoacetamide and N-ethyl maleimide) and glutathione on ...
Li, Li
core   +6 more sources

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Pleiotropic effects of the HMG-CoA reductase inhibitors

open access: yes, 2011
Christos G Mihos, Orlando SantanaColumbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL, USAAbstract: The HMG-CoA reductase inhibitors (statins) are used extensively in the treatment of hyperlipidemia.
Santana O   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy